IE45505L - 1,5-disubstituted-2-pyrrolidones. - Google Patents

1,5-disubstituted-2-pyrrolidones.

Info

Publication number
IE45505L
IE45505L IE771641A IE164177A IE45505L IE 45505 L IE45505 L IE 45505L IE 771641 A IE771641 A IE 771641A IE 164177 A IE164177 A IE 164177A IE 45505 L IE45505 L IE 45505L
Authority
IE
Ireland
Prior art keywords
pyrrolidones
disubstituted
ca1077948a
disubstitued
prostaglandin
Prior art date
Application number
IE771641A
Other versions
IE45505B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE654/80A priority Critical patent/IE45506B1/en
Publication of IE45505L publication Critical patent/IE45505L/en
Publication of IE45505B1 publication Critical patent/IE45505B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A series of 1,5-disubstitued-2-pyrrolidones which are prostaglandin-like in character and the processes for making them are disclosed. [CA1077948A]
IE1641/77A 1976-08-06 1977-08-05 1,5-disubstituted-2-pyrrolidones IE45505B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE654/80A IE45506B1 (en) 1976-08-06 1977-08-05 1,5-disubstituted-2-pyrrolidones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
IE45505L true IE45505L (en) 1978-02-06
IE45505B1 IE45505B1 (en) 1982-09-08

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1641/77A IE45505B1 (en) 1976-08-06 1977-08-05 1,5-disubstituted-2-pyrrolidones

Country Status (31)

Country Link
JP (2) JPS5321159A (en)
AR (1) AR217080A1 (en)
AT (1) AT362887B (en)
AU (1) AU508007B2 (en)
BE (1) BE857506A (en)
BG (1) BG31073A3 (en)
CA (1) CA1077948A (en)
CH (1) CH624934A5 (en)
CS (1) CS221269B2 (en)
DD (2) DD143768A5 (en)
DE (1) DE2735904A1 (en)
DK (1) DK352077A (en)
ES (2) ES461388A1 (en)
FI (1) FI70009C (en)
FR (1) FR2369260A1 (en)
GB (2) GB1556570A (en)
GR (1) GR68688B (en)
HU (1) HU180273B (en)
IE (1) IE45505B1 (en)
IL (1) IL52615A (en)
LU (1) LU77936A1 (en)
NL (1) NL7708637A (en)
NO (1) NO772752L (en)
NZ (1) NZ184806A (en)
PH (1) PH17398A (en)
PL (2) PL112931B1 (en)
PT (1) PT66891B (en)
SE (1) SE423813B (en)
SU (3) SU703016A3 (en)
YU (1) YU192577A (en)
ZA (1) ZA774704B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
ATE327751T1 (en) 2000-01-31 2006-06-15 Pfizer Prod Inc USE OF PROSTAGLAND RECEPTOR 4 ACTIVATORS FOR THE TREATMENT OF ACUTE OR CHRONIC RENAL INSUFFICIENCY
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
EA200300379A1 (en) * 2000-11-27 2003-08-28 Пфайзер Продактс Инк. SELECTIVE AGONISTS OF EP4 RECEPTOR IN THE TREATMENT OF OSTEOPOROSIS
JP4273407B2 (en) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Therapeutic agent for bone loss diseases comprising EP4 agonist as an active ingredient
ATE336247T1 (en) * 2002-03-18 2006-09-15 Pfizer Prod Inc USE OF SELECTIVE EP4 RECEPTOR AGONISTS TO TREAT DISEASES
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
WO2004065365A1 (en) * 2003-01-21 2004-08-05 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (en) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22PIRORIDONJUDOTAINO SEIHO
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (en) * 1975-06-27 1977-01-13 Hoechst Ag PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Also Published As

Publication number Publication date
CH624934A5 (en) 1981-08-31
CA1077948A (en) 1980-05-20
SU703016A3 (en) 1979-12-05
JPS5555161A (en) 1980-04-22
ES471349A1 (en) 1979-09-16
PL112931B1 (en) 1980-11-29
FI70009C (en) 1986-09-12
IE45505B1 (en) 1982-09-08
AU508007B2 (en) 1980-03-06
GB1556569A (en) 1979-11-28
DE2735904A1 (en) 1978-02-09
PT66891A (en) 1977-09-01
ATA579477A (en) 1980-11-15
AU2751577A (en) 1979-02-08
HU180273B (en) 1983-02-28
NZ184806A (en) 1980-04-28
FI772376A7 (en) 1978-02-07
FR2369260B1 (en) 1982-02-12
FI70009B (en) 1986-01-31
AT362887B (en) 1981-06-25
BE857506A (en) 1978-02-06
CS221269B2 (en) 1983-04-29
PT66891B (en) 1979-01-26
DD136135A5 (en) 1979-06-20
SE7708642L (en) 1978-02-07
PL200124A1 (en) 1978-05-22
SU818480A3 (en) 1981-03-30
SU850000A3 (en) 1981-07-23
FR2369260A1 (en) 1978-05-26
LU77936A1 (en) 1978-04-27
GB1556570A (en) 1979-11-28
ES461388A1 (en) 1978-12-01
AR217080A1 (en) 1980-02-29
DD143768A5 (en) 1980-09-10
JPS5531147B2 (en) 1980-08-15
ZA774704B (en) 1978-06-28
JPS5321159A (en) 1978-02-27
GR68688B (en) 1982-02-01
NL7708637A (en) 1978-02-08
YU192577A (en) 1983-04-30
SE423813B (en) 1982-06-07
IL52615A0 (en) 1977-10-31
DK352077A (en) 1978-02-07
IL52615A (en) 1981-09-13
PH17398A (en) 1984-08-08
BG31073A3 (en) 1981-10-15
JPS585196B2 (en) 1983-01-29
NO772752L (en) 1978-02-07

Similar Documents

Publication Publication Date Title
AU508612B2 (en) 8 c 1. a r C
AU503557B2 (en) N, n' alkylene-bis-tetrabromo-phthalimides
AU2228677A (en) P. c. v valve
AU503871B2 (en) 1. 2-benzothiazolin-3-one
AU512404B2 (en) 2, 6-Methano-2H-l-Benzoxocins
AU508007B2 (en) 1, 5-Disubstituted-2-Pyrrolidones
AU515495B2 (en) 5, 5-trimethylhexanoyl-ferrocene
AU500386B2 (en) 1,2,6-thidiazinones
AU511988B2 (en) O-ethyl-s-n-propyl-0,2,2,2-trihaloethy_phosphoro-thiolates/thionothiolates
AU505974B2 (en) 3', 4'-dideoxykanamcin b
IL51441A (en) 3-aminomethyl-2,9-dioxatricyclo(4,3,1,33.7)decane derivatives and their production
GB1541546A (en) 1-aminitricyclo 4.3.1.1 2,5 undecane and process for the preparation thereof
AU507282B2 (en) 3, 3-Dimethylpent-4-Endic Acid
AU514741B2 (en) 5,6-dehydropenicillins
AU510041B2 (en) Manufacture of 1, 1 Dihalo-4-methyl-l., 3-pentadienes
GB1541544A (en) 1-halogenotricyclo 4.3.1.1 2,5 undecane and process for the preparation thereof
AU488952B2 (en) 2. 4-diamino-5-benzylpyrimidines
GB1541545A (en) 1-acetylaminotricyclo 4.3.1.1 2,5 undecane and process forthe preparation thereof
AU520088B2 (en) 1, 2, 3, 4-tetrahydro-naphthalenes
AU492181B2 (en) 13,14-dehydro-11-deoxy-prostaglandins and process for their preparation
AU2160877A (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
MY8200244A (en) 2,3-dihydro-2-oxo-3-benzo[b]thiophenecarboxides
AU504824B2 (en) P. v. c. suspension polymerisation
AU3200977A (en) 5-anyl-3, 6-dihydro-l, 3, 4-oxadiazin-2-ones
AU517326B2 (en) 7-HALO-3, 20-DIOXO-l, 4-PREGNADIENES AND 4 PREGNENES AND THEIR PREPARATION